semaglutide weight loss grayhawk Therapy Semaglutide for Medical Weight Loss

Are you tired of trying to shed those stubborn pounds with little to no success

We present the case of a 32-year-old woman with no prior medical history who developed hematochezia and abdominal pain after six weeks of tirzepatide therapy for weight loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that acts on the same receptor as the endogenous incretin hormone which works by selectively binding and activating the GLP-1 receptor to increase glucose-dependent insulin secretion, reducing appetite, and slows gastric emptying

Here's the verdict.

Relevance for patients: A pharmacokinetically comparable semaglutide injection may help expand access to long-term semaglutide treatment where innovator product cost or availability may limit patient use.